Get involved. Stay informed.
If you share our passion for improving patients’ lives through medical innovation and want to get involved in our audacious vision to shape the future of human health, we invite you to connect with us!
Join one of our events below, sign up for our newsletter, read our blog, get notified about upcoming podcasts, follow us on social media, or just reach out via email.
Welcome to the Fogarty Innovation family!
Upcoming Events

Principled Decision-Making
Interview and Reception
Wednesday, March 29, 4-6:00pm
Tyler Shultz’s gutsy decision to blow the whistle on Theranos ten years ago had major consequences for the company and its founders. It also resulted in increased scrutiny of the medtech startup space and exacted a huge personal cost.
What does Tyler believe today given the perspective of time? Was doing the right thing worth it? What is next for him as a founder? Please join us for one-on-one conversation with Fogarty Innovation CEO Andrew Cleeland on Principled Decision-Making.
This is a hybrid event. Email Fogarty Education to inquire about in-person or zoom attendance.

Designing and Implementing a
Quality Management System
Tuesday, April 4, 12 -1:30pm
Why does a quality management system (QMS) matter? What is the best way to approach considering and implementing one? How do you figure out the appropriate level of complexity for your company stage, and how will you know when to change or upgrade?
Don’t miss this opportunity to learn everything you need to know about designing and implementing a QMS from Grace Li, VP Quality and Regulatory at Enspectra Health. This is an in-person event.
Email Fogarty Education to register.
The Impact of Changing IP Policy
Monday, April 10, 5:30 – 6:30 pm PT
Join the Stanford Biodesign Policy Program and the Council for Innovation Promotion for a roundtable discussion on critical issues in IP law and policy, including the extent to which medical devices and diagnostics are eligible for patent protection, how much patent validity can be challenged after patents are granted, and whether patent rights should be limited for vaccines or critical therapies. The impact of these policy decisions could shape innovation for the foreseeable future.
From the Innovator’s Workbench –
K. Angela Macfarlane
Wednesday, April 19, 6 – 7pm
Join Stanford Biodesign for a lively evening with
K. Angela Macfarlane! In a candid interivew with Lyn Denend, Biodesign director of academic programs, Angela will share lessons from her remarkable career with a special focus on how she has cultivated her unique leadership style.
Angela is the CEO of Perceive Biotherapeutics, managing member of ForSight Labs, and a board member of Fogarty Innovation.
Medtech Trailblazers Podcasts
Notify Me of New Podcasts
Blog
Nina Capital Shares Insights on Early-Stage Financing and Trends from Across the Pond
After 13 years working with entrepreneurs, investors, universities and corporations in Silicon Valley, Marta-Gaia Zanchi, the founding director of Stanford Biodesign’s digital health program, moved to Barcelona to launch Nina Capital. Her goal was to invest in and...
Diverse Community College Students Explore “Pathways in Health Technology” With Innovative Program
Stanford Biodesign, Fogarty Innovation and five local medical device companies have teamed up to introduce a new program offered through the Diversity by Doing (DxD) HealthTech initiative. Twenty-seven students selected from 10 Bay Area community colleges are...
Fogarty Innovation Graduate Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes
Fogarty graduate Raydiant Oximetry, Inc., kicked off its Series B financing round with an investment from the March of Dimes Innovation Fund. The cash infusion comes on the heels of a successful clinical study that showed Raydiant Oximetry’s innovative technology,...
In the News
El Camino Health is First to Adopt FloPatch Advanced Ultrasound Technology for Sepsis Management
FloPatch was developed by Flosonics, a graduate of Fogarty Innovation.
St. Cloud Hospital Removes Heart Tumor Without Open Heart Surgery
The procedure used EchoPixel 4D hologram technology. EchoPixel is a graduate of Fogarty Innovation.
DxD Takes Action on Making Medtech Diverse
DxD HealthTech works to drive equity in medtech by expanding access to development and decision-making in the space
Videocasts
Entrepreneurship Programs
Contact us
Get in touch
*= Required fields
Please complete the math equation to verify that you are not a robot.
Fogarty Innovation
2495 Hospital Drive
Suite 300
Mountain View, CA 94040